Revolution Medicines (RVMD) Share-based Compensation (2019 - 2026)
Revolution Medicines (RVMD) posted Share-based Compensation of $277.2 million for Q2 2026, down 3.75% on a QoQ basis from $288.0 million in Q1 2026, and up 55.29% year-over-year from $178.5 million in Q2 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Share-based Compensation (2019 - 2026) Analysis & Trends
Revolution Medicines has reported Share-based Compensation for 8 years, with the latest figure at $277.2 million in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 55.29% year-over-year to $277.2 million in Q2 2026; TTM through Jun 2026 was $277.2 million, a 55.29% increase from a year earlier, with the FY2025 full-year figure at $208.4 million, up 75.42% from the prior year.
- Share-based Compensation was $277.2 million for Q2 2026 at Revolution Medicines, down from $288.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $288.0 million in Q1 2026, with the low at $7.9 million in Q1 2022.
- Average Share-based Compensation over 5 years is $75.2 million, with a median of $23.8 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Share-based Compensation tumbled 60.23% in 2022, then soared 1048.14% in 2026.
- Over 5 years, Share-based Compensation stood at $8.3 million in 2022, then soared by 205.76% to $25.4 million in 2023, then dropped by 11.75% to $22.4 million in 2024, then jumped by 50.17% to $33.7 million in 2025, then soared by 722.65% to $277.2 million in 2026.
- The last three Share-based Compensation figures came in at $277.2 million (Q2 2026), $288.0 million (Q1 2026), and $33.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | -950.00 Mn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 247.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 108.10 Mn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | 277.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 277.20 Mn |
| Mar 31, 2026 | 288.00 Mn |
| Dec 31, 2025 | 33.70 Mn |
| Sep 30, 2025 | 177.70 Mn |
| Jun 30, 2025 | 178.50 Mn |
| Mar 31, 2025 | 25.08 Mn |
| Dec 31, 2024 | 22.44 Mn |
| Sep 30, 2024 | 120.80 Mn |
| Jun 30, 2024 | 118.70 Mn |
| Mar 31, 2024 | 16.21 Mn |
| Dec 31, 2023 | 25.43 Mn |
| Sep 30, 2023 | 13.67 Mn |
| Jun 30, 2023 | 12.98 Mn |
| Mar 31, 2023 | 10.26 Mn |
| Dec 31, 2022 | 8.32 Mn |
| Sep 30, 2022 | 8.16 Mn |
| Jun 30, 2022 | 8.10 Mn |
| Mar 31, 2022 | 7.88 Mn |
| Dec 31, 2021 | 20.91 Mn |
| Sep 30, 2021 | 6.03 Mn |
API Access
Revolution Medicines Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();